HC Wainwright Reaffirms “Buy” Rating for OPKO Health (NASDAQ:OPK)
HC Wainwright restated their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a report released on Wednesday morning,Benzinga reports. HC Wainwright currently has a $3.00 price target on the biotechnology company’s stock. Other equities analysts have also recently issued reports about the stock. StockNews.com raised shares of OPKO Health from a […]
